Clinical Trial Update: Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Teneligliptin to Linagliptin in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)
• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Handok Inc. | Conditions: Type2 Diabetes Mellitus | Phase 4 | Status: COMPLETED